Dihydrofolate reductase inhibitors for use as antimicrobial agents.
Drug-resistant bacteria pose an increasingly serious threat to mankind all over the world. However, the currently available clinical treatments do not meet the urgent demand.Therefore, it is desirable to find new targets and inhibitors to overcome the problems of antibiotic resistance. Dihydrofolate reductase (DHFR) is an important enzyme required to maintain bacterial growth, and hence inhibitors of DHFR have been proven as effective agents for treating bacterial infections. This review provides insights into the recent discovery of antimicrobial agents targeting DHFR. In particular, three pathogens, Escherichia coli (E. coli), Mycobacterium tuberculosis(Mtb) and Staphylococcus aureus(S. aureus), and research strategies are emphasized. DHFR inhibitors are expected to be good alternatives to fight bacterial infections.
['He|Juan|J|', 'Qiao|Wenliang|W|', 'An|Qi|Q|', 'Yang|Tao|T|', 'Luo|Youfu|Y|']
D000890:Anti-Infective Agents D005493:Folic Acid Antagonists D013762:Tetrahydrofolate Dehydrogenase
DHFR Bacterial infections Escherichia coli Mycobacterium tuberculosis Staphylococcus aureus